Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.7 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |